Veterinary Drug Handbook (VDH) is the reference veterinarians turn to when they want an independent source of information on the drugs that are used in veterinary medicine today.

Denagard-Medicated Premix

Product Type: OTC ANIMAL DRUG LABEL
Autor Name: Novartis Animal Health US, Inc.
Code Source: 58198-0700
Route of Administration: ORAL

Denagard 10

Generic: tiamulin

Ingredients:

  • TIAMULIN FUMARATE TIAMULIN : Active ingredient - basis of strength - 22 g in 1 kg

Package Description:

  • 15.9 kg in 1 BAG

Denagard ® 10
(tiamulin)
Medicated Premix
Type A Medicated Article
For manufacture of medicated swine feed only

(tiamulin hydrogen fumarate): 10 g/lb

roughage product, mineral oil
See reverse side for use directions, cautions and warnings.
NADA 139-472, Approved by FDA
Net Weight: 35 lb (15.9 kg)
Denagard ® 10
(tiamulin)
Medicated Premix
Type A Medicated Article
For use in animals only.
Store in a dry place.
Indications Directions Amount of Denagard 10 Per Ton Tiamulin hydrogen fumarate in Complete Feed Per Ton Withdrawal Period (days)
For treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin Feed continuously as the sole ration for 14 days 20 lb 200 g 7
For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis Feed continuously as the sole ration for not less than 10 days 3.5 lb 35 g 2
For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin Feed continuously as the sole ration 3.5 lb 35 g 2


Observe withdrawal time shown in table above. Keep out of reach of children. Avoid contact with skin. Direct contact with skin or mucous membranes may cause irritation.

Do not feed undiluted. Do not use in feeds for animals other than swine. The effects of tiamulin on swine reproductive performance, pregnancy and lactation have not been determined.
Swine being treated with Denagard (tiamulin) should not have access to feeds containing polyether ionophores (e.g., lasalocid, monensin. narasin, salinomycin and semduramicin) as adverse reactions may occur. If signs of toxicity occur, discontinue use.
Restricted Drug (California): Use only as directed.
For more information or to report adverse effects, call 1-800-637-0281.
Denagard ® is a registered trademark of Novartis AG.
Product #609425
NAH/DEN10-MP/BGL/5
Marketed by:
Novartis Animal Health US, Inc.
Greensboro, NC 27408 U.S.A.

Denagard ® 10 (tiamulin)
Medicated Premix
Type A Medicated Article
For manufacture of medicated swine feed only Active Ingredient: (tiamulin
hydrogen fumarate): 10 g/lb
Ingredients: roughage product,
mineral oil
See reverse side for use directions, cautions and warnings.
NADA 139-472, Approved by FDA Net Weight: 35 lb (15.9 kg)
NOVARTIS ANIMAL HEALTH

?® 10 (tiamulin) Medicated Premix Type A Medicated Article NADA 139-472, Approved by FDA Net Weight: 35 lb (15.9 kg) NOVARTIS ANIMAL HEALTH
Denagard-Medicated Premix

Click here add new comment/review78

veterinary-help.com

© 2011-2025 Veterinary Clinics, Diagnoses, Terms and Drug Handbook Online

×
Wait 20 seconds...!!!